Protothecal bursitis after simultaneous kidney/liver transplantation: a case report and review

Transpl Infect Dis. 2016 Apr;18(2):266-74. doi: 10.1111/tid.12496. Epub 2016 Feb 22.

Abstract

Solid organ transplantation is an accepted therapy for end-stage diseases of the kidneys, liver, heart, and lungs. Unfortunately, transplantation is associated with infectious complications. Here, we present a case report of Prototheca wickerhamii olecranon bursitis and review all of the cases in solid organ transplant (SOT) recipients published in the literature to date. In our patient, the infection resolved with surgical therapy and limited antifungal therapy, and no symptoms have recurred over 24 months of follow-up. A review of the literature suggests that 50% of SOT recipients with Prototheca infection present with disseminated infection, and the overall mortality is 75%. More studies are required to determine the optimal management of protothecosis in this population.

Keywords: Prototheca; antifungals; olecranon bursitis; surgery; transplant.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Bursitis / microbiology*
  • Humans
  • Immunocompromised Host
  • Infections / etiology*
  • Infections / therapy*
  • Kidney Transplantation / adverse effects*
  • Liver Transplantation / adverse effects*
  • Male
  • Prototheca*